Peer Review History
| Original SubmissionNovember 7, 2019 |
|---|
|
PONE-D-19-31030 Recreational drug use among Nigerian university students: prevalence, determinants and frequency of use PLOS ONE Dear Dr Ajayi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Apr 04 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Aparup Das, Ph. D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed: https://doi.org/10.1017/S0021932018000330 In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Additionally, in your Introduction and Discussion please cite and discuss your previous ONE publication and describe the current studies relationship to that manuscript. Ensure you cite any publications using the same dataset. Further consideration is dependent on these concerns being addressed. 3. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 3 in your text; if accepted, production will need this reference to link the reader to the Table. 4. Your ethics statement must appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please also ensure that your ethics statement is included in your manuscript, as the ethics section of your online submission will not be published alongside your manuscript. Additional Editor Comments (if provided): The manuscript has been reviewed by two independent reviewers and both have found the manuscript to be of merit for potential publication. However, they have indicated several issues which the authors need to address before the manuscript is re-considered. The authors are accordingly advised to revise the manuscript as suggested by the reviewers. A table consisting of point-wise replies/corrections made in the manuscript (with page and line number) independently for each reviewer should be submitted along with the revised manuscript. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This manuscript is about the recreational drug use and associated factors among Nigerian university students and has the potential to contribute to the literature if revised. The introduction is lengthy and organization could be improved. The stated theory guiding the analysis is only mentioned in the introduction and results are sometimes overstated given the data. Below are suggestions for revision. Abstract • The authors stated that they elicit determinants of recreational drug use, but it is a cross-sectional study so authors should be careful with using causal language. Background • Authors state abuse of opioids is growing in developed and more recently developing nations, yet the citations for developing nations are older than the citations for developed nations. Thus, it does not appear to be more recent in developing nations. • It is unclear what the study is about until the very end of the background. Since the first sentence is about opioids, it appeared that that’s what the manuscript is about. Yet almost all of the studies cited do not report these substances, and the study measures codeine, tramadol, and marijuana together. • The introduction can be better organized. Since SEM is used as the theoretical framework, that should be introduced earlier and the introduction follow that as the outline for drug use among young adults. That should lead to a paragraph before the hypotheses about what this manuscript contributes to the literature that we do not already know, and the purpose of the study. Method • Why were codeine, marijuana, and Tramadol combined into 1 question? The authors should explain why they did not assess substances separately. • How is “ease tension” defined? • Independent variables: More information is needed on each of the variables. How was age categorized? It is mentioned that family support is monetary and emotional. How was the question phrased to students? Did they understand the emphasis was on emotional support? And what family is included in family support? Was it specified that it was parents? Religious background was not included. • It is unclear how SEM is applied in the methodology; authors should consider how the variables fit into the theoretical framework. Discussion • The authors state their study provides data to help address the opioid crisis, yet marijuana was included in the question so there is no way to know how many students actually used codeine or tramadol. The authors portray throughout the manuscript that this assesses opioid use, yet there is no way to know how many students actually used opioids. As such, the emphasis should be taken off of opioids and state recreational drug use instead. • Some of the conclusions made are beyond the scope of the study. The authors mention mothers may be the pillar of support but that is unknown since who the support is provided by is not measured (just family). The authors should carefully consider all of their conclusions and ensure they are supported by results. • The authors should consider other limitations mentioned in previous statements. • There is no mention of SEM in the discussion and how it is applied to the results. Reviewer #2: The manuscript fills in critical gap about the exposure of Nigerian university students to recreational drug use, and the finding about the protective role of mother in this scenario is enlightening. Still, few things remain unanswered in the paper like whether these mothers are working/non-working, what is the age range of participants, in which courses the students were enrolled (undergraduate/postgraduate) because that will predict their capacity to handle the enticements for drug use. Similarly, type of polygamy needs to be clarified. According to the manuscript when either parents are not alive then there is greater tendency to use recreational drugs, and this could be explored further more rigorously later. The United Nations Office on Drug Use and Crime came up with "Drug Use in Nigeria, 2018" which has elaborately discussed about use of recreational drug use and needs to be referred to by the authors for future studies. It is suggested to make the language of the manuscript crisper and more palatable and freer from typographical errors. I wish the authors all the best for their future endeavors. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-19-31030R1 Recreational drug use among Nigerian university students: prevalence, correlates and frequency of use PLOS ONE Dear Dr Ajayi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. I now have the comments of the two reviewers who have reviewed this manuscript in its original form. As you can see from their comments, both have indicated 'minor revision'. I therefor would ask you to revise the manuscript carefully based on individual comments put by both the reviewers for further consideration. We would appreciate receiving your revised manuscript by May 23 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Aparup Das, Ph. D. Academic Editor PLOS ONE Additional Editor Comments (if provided): Please see my comments above [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Overall, this manuscript is much improved. There are still some aspects the authors should consider. Authors should ensure that the manuscript is written in past-tense since they already conducted the study, that all acronyms are defined (i.e., SSA for sub-Saharan Africa), and should consider hiring a copy-editor. The introduction could be further refined. The authors only need 1 or 2 paragraphs introducing recreational drug use and why it needs to be addressed among this population. Then they should introduce their theory/model and how those variables at each level are related to recreational drug use. In the introduction, the authors introduce factors in the introduction related to SEM, yet do not evaluate all of those factors in analyses. If the factors remain in the introduction, it should be discussed in the limitations sections why they were not included. What are the implications of these findings as it relates to SEM? Rather than just listing the results of the different variables, what is the implication of these results (or where does future research need to go) to adequately apply SEM to recreational drug use among university students. The authors may want to consider another model as the focus seems to be on demographic and family/household factors rather than factors from the various SEM levels. Reviewer #2: The study advances the discourse of recreational drug use in the Nigerian context, especially for the Nigerian youth going to universities and identifies protective factors against drug use in this context. The study has potential for publication and these points must be considered for the same: Using SEM the study tries to explore various factors correlated with use of recreational drugs. In the abstract though there is no mention of SEM. In this model, however, how authors have defined and differentiated between the social and environmental factors is not clear. Say for e.g. why religion is considered as an environmental factor here – are there any previous studies which take such notions into consideration and/or relate recreational drug use with religion? This is so because it is more of a socio-cultural construct than an environmental one. Then, in table no. 1 religion is given as a demographic factor and later as an environmental one. I feel fitting of the present study into SEM is merely a post-hoc exercise and I have reservations about considering religion as an environmental and not social factor in the present study. The authors should shed more light on this aspect. In the present study while delineating SEM the authors describe that they have taken into consideration the structure of family and not monitoring of young ones (pg 5). Any particular reason for not considering monitoring as a potential factor. There are few instances of conflict in the manuscript which need to be resolved while revising like – On page 4 the sentence “We focused ….. recreational purpose.” Appears while later they show association between the mother’s influence on taking the recreational drugs, and here they are of the view that university students are free from parental control and supervision. Similarly, on pg. 5 it says “However, the federal ….. in Nigeria.”, then how come the participants in the present study were getting it for use. In continuation of the previous point, the authors can consider the place of indulging in recreational drug which has not been delineated. This could be an environmental factor in the study. This is important because had the place been home then family factor comes into play. But if the place is university then already there is no role of family/parents there and the peer group assumes importance. About study design - Was the study tool i.e. self-designed questionnaire influenced by some already existing questionnaire? I feel it is better to use “gender” instead of “sex” as an Independent variable. There is a typo when dealing with Independent variable – “school fee” should be “university fee”. Results - in the present study the way in which use of recreational drugs has been explored confounds the fact that whether the users use it for “pleasure” or “to ease tension/stress”. The two things could not and should not be mixed in a single question because then the motivation for using the recreational drug gets diffused and not expressed. Further, the study does not provide explanations for various findings like – why there is lesser current drug use among the female students than the male ones. Similarly, what is the reason for “our study shows that the nuclear family structure was independently associated with a lower likelihood of drug use in the unadjusted model” (pg. 16). Discussion section– There are speculative sentences like “it is possible that the prevalence of drug use has increased since the 1990s.” (pg. 15) even though literature and reports like "Drug use in Nigeria, 2018" by United Nations Office on Drug Use and Crime are there. Further, it is felt that it is alright to to relate with presence of mother in the household, but this could be possible in a nuclear family scenario also where mother is also present along with the father and children. Lastly, it is advised to the authors to not go for overarching ambitious conclusions which are beyond the ambit of present study. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Recreational drug use among Nigerian university students: prevalence, correlates and frequency of use PONE-D-19-31030R2 Dear Dr. Ajayi, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Aparup Das, Ph. D. Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-19-31030R2 Recreational drug use among Nigerian university students: prevalence, correlates and frequency of use Dear Dr. Ajayi: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Aparup Das Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .